Technical Analysis for CUR - Neuralstem, Inc.

Grade Last Price % Change Price Change
grade F 1.77 -2.75% -0.05
CUR closed down 2.75 percent on Friday, September 13, 2019, on 43 percent of normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical CUR trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Shooting Star Candlestick Bearish -2.75%
Lizard Bearish Bearish Day Trade Setup -2.75%
1,2,3 Retracement Bearish Bearish Swing Setup -2.75%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.75%
Bollinger Band Squeeze Range Contraction -2.75%
Narrow Range Bar Range Contraction -2.75%
1,2,3 Retracement Bearish Bearish Swing Setup -2.75%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.75%

Older signals for CUR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. Its stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons. Its products under development include NSI – 566, which has completed Phase I clinical trial for the proposed treatment of amyotrophic lateral sclerosis, as well as for chronic spinal cord injury and motor deficits due to ischemic stroke; and NSI – 189, a small molecule pharmaceutical compound, which is in Phase Ib clinical trial for the treatment of major depressive disorder. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
Biotechnology Biopharmaceutical Life Sciences Biology Stem Cells Amyotrophic Lateral Sclerosis Major Depressive Disorder Stem Cell Therapy Treatment Of Major Depressive Disorder Ischemic Stroke
Is CUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.4
52 Week Low 1.5
Average Volume 113,364
200-Day Moving Average 7.369
50-Day Moving Average 3.2174
20-Day Moving Average 1.752
10-Day Moving Average 1.745
Average True Range 0.2119
ADX 40.93
+DI 15.0249
-DI 29.5485
Chandelier Exit (Long, 3 ATRs ) 1.4035
Chandelier Exit (Short, 3 ATRs ) 2.1357
Upper Bollinger Band 1.9348
Lower Bollinger Band 1.5692
Percent B (%b) 0.55
BandWidth 20.86758
MACD Line -0.3341
MACD Signal Line -0.4694
MACD Histogram 0.1352
Fundamentals Value
Market Cap 21.45 Million
Num Shares 12.1 Million
EPS -2.22
Price-to-Earnings (P/E) Ratio -0.80
Price-to-Sales 977.06
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.89
Resistance 3 (R3) 1.90 1.88 1.87
Resistance 2 (R2) 1.88 1.85 1.87 1.86
Resistance 1 (R1) 1.82 1.83 1.81 1.81 1.86
Pivot Point 1.80 1.80 1.79 1.79 1.80
Support 1 (S1) 1.74 1.77 1.73 1.73 1.68
Support 2 (S2) 1.72 1.75 1.71 1.68
Support 3 (S3) 1.66 1.72 1.67
Support 4 (S4) 1.65